Drugs and pharmaceuticals: management of intoxication and antidotes
- PMID: 20358691
- PMCID: PMC7123602
- DOI: 10.1007/978-3-7643-8338-1_12
Drugs and pharmaceuticals: management of intoxication and antidotes
Abstract
The treatment of patients poisoned with drugs and pharmaceuticals can be quite challenging. Diverse exposure circumstances, varied clinical presentations, unique patient-specific factors, and inconsistent diagnostic and therapeutic infrastructure support, coupled with relatively few definitive antidotes, may complicate evaluation and management. The historical approach to poisoned patients (patient arousal, toxin elimination, and toxin identification) has given way to rigorous attention to the fundamental aspects of basic life support--airway management, oxygenation and ventilation, circulatory competence, thermoregulation, and substrate availability. Selected patients may benefit from methods to alter toxin pharmacokinetics to minimize systemic, target organ, or tissue compartment exposure (either by decreasing absorption or increasing elimination). These may include syrup of ipecac, orogastric lavage, activated single- or multi-dose charcoal, whole bowel irrigation, endoscopy and surgery, urinary alkalinization, saline diuresis, or extracorporeal methods (hemodialysis, charcoal hemoperfusion, continuous venovenous hemofiltration, and exchange transfusion). Pharmaceutical adjuncts and antidotes may be useful in toxicant-induced hyperthermias. In the context of analgesic, anti-inflammatory, anticholinergic, anticonvulsant, antihyperglycemic, antimicrobial, antineoplastic, cardiovascular, opioid, or sedative-hypnotic agents overdose, N-acetylcysteine, physostigmine, L-carnitine, dextrose, octreotide, pyridoxine, dexrazoxane, leucovorin, glucarpidase, atropine, calcium, digoxin-specific antibody fragments, glucagon, high-dose insulin euglycemia therapy, lipid emulsion, magnesium, sodium bicarbonate, naloxone, and flumazenil are specifically reviewed. In summary, patients generally benefit from aggressive support of vital functions, careful history and physical examination, specific laboratory analyses, a thoughtful consideration of the risks and benefits of decontamination and enhanced elimination, and the use of specific antidotes where warranted. Data supporting antidotes effectiveness vary considerably. Clinicians are encouraged to utilize consultation with regional poison centers or those with toxicology training to assist with diagnosis, management, and administration of antidotes, particularly in unfamiliar cases.
Similar articles
-
New developments in the therapy of intoxications.Toxicol Lett. 2002 Feb 28;127(1-3):299-305. doi: 10.1016/s0378-4274(01)00512-4. Toxicol Lett. 2002. PMID: 12052670 Review.
-
[Decontamination and antidotes in acute cases of poisoning].Ther Umsch. 2009 May;66(5):331-4. doi: 10.1024/0040-5930.66.5.331. Ther Umsch. 2009. PMID: 19401982 Review. German.
-
[Charcoal, cocaine and rattlesnakes: evidence-based treatment of poisoning].Anaesthesist. 2013 Oct;62(10):824-31. doi: 10.1007/s00101-013-2229-z. Anaesthesist. 2013. PMID: 24036518 Review. German.
-
Fundaments of Toxicology-Approach to the Poisoned Patient.Adv Chronic Kidney Dis. 2020 Jan;27(1):5-10. doi: 10.1053/j.ackd.2019.12.001. Adv Chronic Kidney Dis. 2020. PMID: 32147001 Review.
-
Clinical applications of commonly used contemporary antidotes. A US perspective.Drug Saf. 1997 Jan;16(1):9-47. doi: 10.2165/00002018-199716010-00002. Drug Saf. 1997. PMID: 9010641 Review.
Cited by
-
The Anti-Cancer Activity of the Naturally Occurring Dipeptide Carnosine: Potential for Breast Cancer.Cells. 2023 Nov 8;12(22):2592. doi: 10.3390/cells12222592. Cells. 2023. PMID: 37998326 Free PMC article. Review.
-
The role of iNOS inhibitors on lung injury induced by gastrointestinal decontamination agents aspiration.J Mol Histol. 2012 Jun;43(3):351-60. doi: 10.1007/s10735-012-9397-z. Epub 2012 Feb 29. J Mol Histol. 2012. PMID: 22374168
-
Gastrointestinal decontamination in the acutely poisoned patient.Int J Emerg Med. 2011 Oct 12;4:65. doi: 10.1186/1865-1380-4-65. Int J Emerg Med. 2011. PMID: 21992527 Free PMC article.
-
The Therapeutic Potential of Carnosine as an Antidote against Drug-Induced Cardiotoxicity and Neurotoxicity: Focus on Nrf2 Pathway.Molecules. 2022 Jul 12;27(14):4452. doi: 10.3390/molecules27144452. Molecules. 2022. PMID: 35889325 Free PMC article. Review.
References
-
- Jones A.W., Dooley J., Murphy J.R. Treatment of choice in barbiturate poisoning; series of twenty-nine cases of barbiturate poisoning treated with pentylenetetrazole (metrazol) and supportive therapy. J Am Med Assoc. 1950;143:884–888. - PubMed
-
- Orwin A., Sim M., Waterhouse J.A.H. A study of the anti-barbiturate effects of bemegride. Br J Psychiatry. 1965;111:531–533. doi: 10.1192/bjp.111.475.531. - DOI
-
- Hirsh K., Wang S.C. Respiratory stimulant effects of ethamivan and picrotoxin. J Pharmacol Exp Ther. 1975;193:657–663. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical